Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 124,986,945
- Total 13F value
- $1,238,517,575
- Share change
- +23,763,999
- Put/Call ratio
- 163%
- SEC-reported price per share
- $9.91
- Number of holders
- 166
- Value change
- +$285,414,998
- Number of buys
- 108
- Number of sells
- 61
- Shares outstanding
- 126,534,885
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
166
Top holders
10
ARQT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Ownership snapshot
Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences VII...
Disclosed value leader
Frazier Life Sciences VII...
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5
13F
Highest disclosed value: $31,255,566
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Frazier Life Sciences VIII, L.P. has the largest disclosed position value at $31.26M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frazier Life Sciences VIII, L.P.'s linked filing trail.
Disclosed position value
Top 5
Frazier Life Sciences VIII, L.P.
$31.26M
ORBIMED ADVISORS LLC
$1.47M
JENNISON ASSOCIATES LLC
$29.28M
Frazier Life Sciences Management,...
$28.31M
MONTANOVA CAPITAL, LLC
$27.37M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$31,255,566
8,827,261 shares
|
— | 24 Oct 2023 |
| ORBIMED ADVISORS LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,469,935
415,142 shares
|
— | 24 Jun 2022 |
| JENNISON ASSOCIATES LLC |
13F
Company
|
—
denominator unverified
|
$29,283,445
9,066,082 shares
|
— | 31 Dec 2023 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
—
denominator unverified
|
$28,308,469
8,764,232 shares
|
— | 31 Dec 2023 |
| MONTANOVA CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$27,368,116
8,473,101 shares
|
— | 31 Dec 2023 |
| Rubric Capital Management LP |
13F
Company
|
—
denominator unverified
|
$21,461,832
6,644,530 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
166
Shares
124,986,945
Rows available
166
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
166
Q1 2024 holders
166
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend